Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

#RemoteDetailing

- PMLiVE

Indefinable, incomparable and enduring: the value of creativity

Building an environment that encourages, nurtures and harnesses creativity

- PMLiVE

Daily Brief: Europe changes mind on Puma drug, Pfizer’s Healthcare Hub, AbbVie and Calico add $1bn to anti-ageing quest

The latest from pharma, biotech and healthcare

Gilead Sciences

Gilead’s Biktarvy gets European approval, setting up battle with GSK

The drug could offset Gilead's disappointing hep C franchise

- PMLiVE

Plasticell and London’s gene therapy pioneers to tackle manufacturing conundrum

New funding will help London build on its gene therapy expertise

- PMLiVE

Diversity and inclusion in the pharma industry

Is there equality in the workplace?

- PMLiVE

Wilmington Healthcare appoints new Commercial Director

Healthcare intelligence provider Wilmington Healthcare, which incorporates HSJ, Binley’s, OnMedica and Wellards, has appointed Sue Plant as Commercial Director for MedTech.

Wilmington Healthcare

- PMLiVE

US approval for first ever cannabis-based medicine

UK company's Epidiolex tipped to be blockbuster

- PMLiVE

Daily Brief: Dementia Fund hits $350m mark, hard Brexit could cost £100bn in trade and troublesome results for Pfizer’s Ibrance

The latest news from across pharma, biotech and healthcare

- PMLiVE

Doing more with less: when ‘client-centricity’ matters most

At a time when companies face continued downward pressure on operational expenditure, doing ‘more with less’ is becoming a fact of life

- PMLiVE

Is flexible working the future?

How adopting a flexible approach allows access for senior talent

- PMLiVE

Boehringer beefs up biologics capacity with €230m investment

New facility to focus on analytical and process development and manufacturing of biologics for trials.

- PMLiVE

Lucid’s “spellbinding” performance prompts multiple wins at Communiqué 2018

Its haul included the Communications Consultancy of the Year

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links